Compounds > gemcitabine
Page last updated: 2024-08-24

gemcitabine and Cirrhosis

gemcitabine has been researched along with Cirrhosis in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (35.71)29.6817
2010's9 (64.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Head, R; Jiang, H; Li, L; Li, Q; Lim, KH; Liu, J; Ruzinova, MB; Wang-Gillam, A; Yu, J; Zhang, D1
Bansal, R; Mardhian, DF; Prakash, J; Storm, G1
Abramian, A; Arden, JM; Ayub, TH; Doeser, A; Hecking, T; Hoeller, T; Kaiser, C; Keyver-Paik, MD; Kuhn, W; Lüders, C; Thiesler, T1
DeNardo, DG; Hawkins, WG; Hegde, S; Herndon, JM; Jiang, H; Knolhoff, BL; Meyer, MA; Nywening, TM; Pachter, JA; Shapiro, IM; Wang-Gillam, A; Weaver, DT; Zhu, Y1
Hwnag, YI; Jeon, J; Kang, JS; Kim, H; Kim, TW; Kim, Y; Lee, WJ; Park, JH; Park, JK1
Chen, K; Chen, X; Duan, W; Han, L; Jiang, Z; Lei, J; Li, J; Li, X; Ma, J; Ma, Q; Ma, Z; Sun, L; Wang, F; Wang, Z; Wu, E; Wu, Z; Xu, Q1
Altug, T; Atalar, B; Dinçbaş, FO; Gedik, N; Ilvan, S; Koca, S; Oksüz, DC; Ozel, S1
Straus, DJ1
Albarello, L; Balzano, G; Braga, M; Capretti, G; Castoldi, R; Cereda, S; Di Carlo, V; Doglioni, C; Pecorelli, N; Reni, M1
Cui, L; Eguchi, D; Fujiwara, K; Ikenaga, N; Kozono, S; Mizumoto, K; Ohuchida, K; Tanaka, M1
Cooper, H; Eisenberg, BL; Freedman, G; Hoffman, JP; Meropol, NJ; Pingpank, JF; Ross, EA; Sasson, AR; Wetherington, RW1
Aronson, M; Dalal, E; Laufer, M; Nativ, O; Sabo, E1
Casallo Blanco, S; Celdrán Gil, J; de Matías Salces, L; Marcos Sánchez, F; Núñez Cuerda, E; Viana Alonso, A1
Bamberg, M; Budach, W; Classen, J; Hehr, T; Paulsen, F1

Reviews

1 review(s) available for gemcitabine and Cirrhosis

ArticleYear
Chemotherapy only for localized Hodgkin lymphoma.
    Journal of internal medicine, 2011, Volume: 270, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachial Plexus; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fibrosis; Gemcitabine; Heart; Hodgkin Disease; Humans; Hypothyroidism; Lung; Lymphedema; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Risk Assessment; Secondary Prevention; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine

2011

Trials

1 trial(s) available for gemcitabine and Cirrhosis

ArticleYear
Impact of Chemotherapy on Retroperitoneal Lymph Nodes in Ovarian Cancer.
    Anticancer research, 2016, Volume: 36, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Deoxycytidine; Female; Fibrosis; Gemcitabine; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Retroperitoneal Space; Taxoids

2016

Other Studies

12 other study(ies) available for gemcitabine and Cirrhosis

ArticleYear
Tumor-Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer.
    Cancer research, 2018, 04-01, Volume: 78, Issue:7

    Topics: Animals; Antimetabolites, Antineoplastic; Cancer-Associated Fibroblasts; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Drug Resistance, Neoplasm; Fibrosis; Gemcitabine; Humans; Interleukin-1 Receptor-Associated Kinases; Interleukin-1beta; Mice; Mice, Knockout; NF-kappa B; Pancreatic Neoplasms; Tumor Microenvironment; Xenograft Model Antitumor Assays

2018
Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo.
    Journal of controlled release : official journal of the Controlled Release Society, 2018, 11-28, Volume: 290

    Topics: Animals; Antimetabolites, Antineoplastic; Cell Differentiation; Cells, Cultured; Deoxycytidine; Ferric Compounds; Fibrosis; Gemcitabine; Humans; Male; Mice, SCID; Nanoparticles; Pancreatic Neoplasms; Pancreatic Stellate Cells; Receptors, G-Protein-Coupled; Receptors, Peptide; Relaxin; Transforming Growth Factor beta; Treatment Outcome

2018
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.
    Nature medicine, 2016, Volume: 22, Issue:8

    Topics: Aminopyridines; Animals; Antimetabolites, Antineoplastic; Carcinoma, Pancreatic Ductal; CD8-Positive T-Lymphocytes; Cell Proliferation; Deoxycytidine; Disease Models, Animal; Disease Progression; Fibrosis; Focal Adhesion Protein-Tyrosine Kinases; Gemcitabine; Humans; Immunoblotting; Immunohistochemistry; Immunotherapy; Immunotherapy, Adoptive; Mice; Pancreatic Neoplasms; Programmed Cell Death 1 Receptor; Reverse Transcriptase Polymerase Chain Reaction; Tumor Escape; Tumor Microenvironment

2016
The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma.
    Oncotarget, 2016, 11-15, Volume: 7, Issue:46

    Topics: Animals; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Disease Models, Animal; Drug Therapy, Combination; Fibrosis; Gemcitabine; Humans; Male; Mice; Neoplastic Stem Cells; Pancreatic Neoplasms; Peptide Fragments; Telomerase; Tumor Burden; Xenograft Model Antitumor Assays

2016
Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression.
    Cancer letters, 2017, 01-28, Volume: 385

    Topics: AMP-Activated Protein Kinases; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Coculture Techniques; Cytokines; Deoxycytidine; Disease Progression; Enzyme Activation; Enzyme Activators; Female; Fibrosis; Gemcitabine; Humans; Metformin; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Pancreatic Neoplasms; Pancreatic Stellate Cells; Paracrine Communication; Phosphorylation; RNA Interference; Signal Transduction; Time Factors; Transfection; Tumor Burden; Xenograft Model Antitumor Assays

2017
The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in vivo study.
    Medical oncology (Northwood, London, England), 2009, Volume: 26, Issue:4

    Topics: Amifostine; Animals; Colitis; Collagen; Combined Modality Therapy; Cystitis; Deoxycytidine; Fibrosis; Gemcitabine; Male; Neoplasm Staging; Pelvic Neoplasms; Radiation-Protective Agents; Radiotherapy Dosage; Rats; Rats, Wistar; Ribonucleotide Reductases; Survival Rate; Treatment Outcome

2009
Preoperative chemotherapy does not adversely affect pancreatic structure and short-term outcome after pancreatectomy.
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2013, Volume: 17, Issue:3

    Topics: Adenocarcinoma; Adipose Tissue; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Female; Fibrosis; Gemcitabine; Humans; Length of Stay; Male; Middle Aged; Neoadjuvant Therapy; Pancreas; Pancreatectomy; Pancreatic Fistula; Pancreatic Neoplasms; Pancreaticoduodenectomy; Postoperative Hemorrhage; Time Factors; Treatment Outcome

2013
Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells.
    Cancer research, 2013, Apr-01, Volume: 73, Issue:7

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Deoxycytidine; Female; Fibrosis; Gemcitabine; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Pancreatic Stellate Cells; Platelet-Derived Growth Factor; Pyridones; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stromal Cells; Tumor Cells, Cultured

2013
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome.
    International journal of gastrointestinal cancer, 2003, Volume: 34, Issue:2-3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Fibrosis; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Pancreatectomy; Pancreatic Neoplasms; Retrospective Studies; Survival Analysis

2003
Antineoplastic effect of gemcitabine in an animal model of superficial bladder cancer.
    Urology, 2004, Volume: 64, Issue:4

    Topics: Administration, Intravesical; Animals; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Cystitis; Deoxycytidine; Drug Screening Assays, Antitumor; Female; Fibrosis; Gemcitabine; Hyperplasia; Injections, Intraperitoneal; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Organ Size; Single-Blind Method; Urinary Bladder Neoplasms; Urothelium

2004
[Lung adenocarcinoma feigning an interstitial lung disease in a 30-year-old man].
    Anales de medicina interna (Madrid, Spain : 1984), 2007, Volume: 24, Issue:6

    Topics: Adenocarcinoma, Papillary; Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiac Tamponade; Cardiomegaly; Cisplatin; Deoxycytidine; Dyspnea; Fibrosis; Gemcitabine; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Lymphatic Metastasis; Male; Radiography

2007
Effect of gemcitabine on acute and late radiation toxicity of skin and underlying soft tissues to single-dose irradiation in a nude mice model.
    International journal of radiation oncology, biology, physics, 2002, May-01, Volume: 53, Issue:1

    Topics: Animals; Connective Tissue; Deoxycytidine; Dose-Response Relationship, Radiation; Fibrosis; Gemcitabine; Mice; Mice, Nude; Radiation-Sensitizing Agents; Skin; Time Factors

2002